Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Blood Cancer Therapeutics Market to Reach $125.5 Billion by 2030, Driven by Precision Medicine Advances and Expanding Immunotherapy Pipelines
GlobeNewswire, Inc.
Boston, Aug. 26, 2026 (GLOBE NEWSWIRE) -- The global blood cancer therapeutics market is projected to grow from $70.8 billion in 2024 to $125.5 billion by 2030, at a compound annual growth rate (CAGR) of 10.2% during 2025–2030, according to Blood...
RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference
GlobeNewswire, Inc.
ALISO VIEJO, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, at 9:30 a.m. ET in Boston,...
HSS Medical Supply Announces the Launch of a New Customer Portal
EIN Presswire
HSS Medical Supply launches a customer portal that simplifies medical supply ordering, account management, repeat purchases, and inventory organization.
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
GlobeNewswire, Inc.
WALTHAM, Mass., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the Wells Fargo 21st Annual Healthcare...
AI Is Reshaping Clinical Nutrition: Precision Therapy, Venture Capital, and the Food-as-Medicine Frontier
GlobeNewswire, Inc.
Boston, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Artificial intelligence is fundamentally transforming clinical nutrition — from parenteral care and infant formula design to chronic disease management and precision dietary therapy.
Global Veterinary Medical Devices Market to Reach $9.1 Billion by 2030, Driven by Rising Pet Ownership and Technological Innovation in Animal Healthcare
GlobeNewswire, Inc.
Boston, Aug. 25, 2026 (GLOBE NEWSWIRE) -- The global veterinary medical devices market is projected to grow from $6.5 billion in 2024 to $9.1 billion by 2030, advancing at a compound annual growth rate (CAGR) of 6.1% during the 2025–2030 forecast...
India Medical Devices Market to reach USD 39.95 Billion by 2035 at 8.3% CAGR
EIN Presswire
India Medical Devices Market to Surge from USD 19.49 Bn in 2026 to USD 39.95 Bn by 2035—By PLI-Backed Domestic Manufacturing, Digital Health Infrastructure NY, CA, UNITED STATES, August 25, 2026 /EINPresswire.com/ -- As per Market Research...
Aptia's U.S. Health Learning Academy Earns Five Brandon Hall Group Excellence Awards
EIN Presswire
Aptia's U.S. Health Learning Academy Earns Five Brandon Hall Group Excellence Awards BOSTON, MA, UNITED STATES, August 25, 2026 /EINPresswire.com/ -- Aptia, a leading provider of employee benefits and pensions administration, today announced...
AI Poised to Reshape Blood Cancer Therapeutics as Investment Surges Past $2 Billion Across Leading Biotech and Pharma Players
GlobeNewswire, Inc.
Boston, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Artificial intelligence is fundamentally redefining the discovery, development, and delivery of blood cancer therapeutics — compressing timelines, sharpening patient selection, and unlocking...
Image Analysis Group (IAG) Expands U.S. Presence with New Boston-Area Office Opening
EIN Presswire
IAG’s strategic Cambridge, MA location strengthens proximity to biotech innovators and accelerates support for imaging-driven clinical trials.
Council of Autism Service Providers Taps Rebecca Thompson as Director of Government Affairs
EIN Presswire
BOSTON, MA, UNITED STATES, September 15, 2026 /EINPresswire.com/ -- The Council of Autism Service Providers (CASP) has hired Rebecca Thompson as director of government affairs.
Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum
GlobeNewswire, Inc.
BOSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (Nasdaq: ODTX) (“Odyssey” or the “Company”), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and...
AI in Drug Discovery Market to reach USD 23.95 Billion by 2035 at 23.9% CAGR
EIN Presswire
AI in Drug Discovery Market to Surge from USD 3.48 Bn in 2026 to USD 23.95 Bn by 2035-By Escalating Drug Development Cost, Exponential Growth in Biomedical Data NY, CA, UNITED STATES, September 17, 2026 /EINPresswire.com/ -- The global AI in...
Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference
GlobeNewswire, Inc.
RADNOR, Pa., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as...
Flu Vaccines Now Available at All Stop & Shop Pharmacies Ahead of Respiratory Virus Season
GlobeNewswire, Inc.
QUINCY, Mass., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Stop & Shop today announced that flu vaccinations for the 2026-2027 season are now available at all of its more than 200 pharmacy locations across the Northeast.
Influential Women Spotlights Porsche Collins: Championing Mental Health Care Through Empathy, Advocacy, And Support
EIN Presswire
CHARLOTTE, NC, UNITED STATES, August 26, 2026 /EINPresswire.com/ -- Licensed Clinical Social Worker and Founder of Empathic Hues Counseling and Consultation Brings More Than 15 Years of Experience to Client-Centered Mental Health Care Charlotte,...
Rezera Announces Plans to Launch the REVEAL-PAD Multi-Center Study Investigating the Role of Inflammation in Patients with Peripheral Artery Disease
GlobeNewswire, Inc.
BOSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Rezera Inc. (the “Company”), a clinical-stage biotechnology company developing a portfolio of internally-invented and wholly-owned oral inhibitors of NLRP3 to address inflammatory drivers of...
Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan
GlobeNewswire, Inc.
-- Approximately 5,000 to 8,000 patients estimated to be living with acquired HO in Japan -- -- Commercial launch in Japan expected by end of 2026, pending final pricing determination -- BOSTON, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Rhythm...
State of the Life Sciences Industry to Be Reviewed in BCC Research's 2026 Second Quarter Outlook, Spotlighting AI-Driven Discovery, Precision Oncology, and Connected Health Adoption
GlobeNewswire, Inc.
Boston, Aug. 25, 2026 (GLOBE NEWSWIRE) -- BCC Research has published its comprehensive mid-year assessment of the global life sciences sector, examining growth trajectories, emerging disruptors, and competitive dynamics across key therapeutic and...
Zealand Pharma – Notification of holding of treasury shares
GlobeNewswire, Inc.
Company announcement – No. 42 / 2026 Zealand Pharma – Notification of holding of treasury shares Copenhagen, Denmark, August 24, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology...
Sign up for:
Massachusetts Healthcare Journal
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.